Behavioral and neurochemical characterization of transgenic mice carrying the human presenilin-1 gene with or without the leucine-to-proline mutation at codon 235

Experimental Neurology

Volumn 183, Issue 2, 2003, Pages 673-681

  Huang, X G ^a,d   Yee, B K ^b   Nag, S ^a,e   Chan, S T H ^a,c   Tang, F ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b ETH ZURICH   (Switzerland)

^c THE UNIVERSITY OF HONG KONG   (Hong Kong)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Alzheimer's disease; Choline acetyltransferase; Object recognition memory; Presenilin 1; Somatostatin; Water maze; Amyloid

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; LEUCINE; PRESENILIN 1; PROLINE; SOMATOSTATIN;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CODON; CONTROLLED STUDY; EVALUATION; HIPPOCAMPUS; MALE; MAZE TEST; MOUSE; NEUROCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; SPATIAL MEMORY; TASK PERFORMANCE; TRANSGENIC MOUSE; WORKING MEMORY;

EID: 0141448940     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00242-5     Document Type: Article

References (37)

1. Aggleton J.P. Behavioural tests for the recognition of non-spatial information by rats. Sahgal A. Behavioural Neuroscience a Practical Approach . Vol. IV:1993;81-94 Oxford Univ. Press, Oxford.
2. Aggleton J.P., Brown M.W. Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behav. Brain Sci. 22:1999;425-489.
3. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., Prada C.M., Kim G., Seekins S., Yager D., Slunt H.H., Wang R., Seeger M., Levey A.I., Gandy S.E., Copeland N.G., Jenkins N.A., Price D.L., Younkin S.G., Sisodia S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1996;1005-1013.
4. Borchelt D.R., Ratovitski T., van Lare J., Lee M.K., Gonzales V., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 19:1997;939-945.
5. Buresova O., Bolhuis J.J., Bures J. Differential effects of cholinergic blockade on performance of rats in the water tank navigation task and in a radial water maze. Behav. Neurosci. 100:1986;476-482.
6. Bush A.I., Pettingell W.H., Multhaup G., d Paradis M., Vonsattel J.P., Gusella J.F., Beyreuther K., Masters C.L., Tanzi R.E. Rapid induction of Alzheimer A beta amyloid formation by zinc. Science. 265:1994;1464-1467.
7. Bussey T.J., Duck J., Muir J.L., Aggleton J.P. Distinct patterns of behavioural impairments resulting from fornix transection or neurotoxic lesions of the perirhinal and postrhinal cortices in the rat. Behav. Brain Res. 111:2000;187-202.
8. Campion D., Brice A., Dumanchin C., Puel M., Baulac M., De La Sayette V., Hannequin D., Duyckaerts C., Michon A., Martin C., Moreau V., Penet C., Martinez M., Clerget-Darpoux F., Agid Y., Frebourg T. A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years. Neuroreport. 7:1996;1582-1584.
9. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., St George Hyslop P., Selkoe D.J. Mutant presenilins of Alzheimer's disease increase production of 42- residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3:1997;67-72.
10. Davies P. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res. 171:1979;319-327.
11. Davies P., Katzman R., Terry R.D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature. 288:1980;279-280.
12. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 391:1998;387-390.
13. De Strooper B., Annaert W., Cupers P., Saftig P., Craessaerts K., Mumm J.S., Schroeter E.H., Schrijvers V., Wolfe M.S., Ray W.J., Goate A., Kopan R. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature. 398:1999;518-522.
14. Duff K., Eckman C., Zehr C., Yu X., Prada C.M., Perez-tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M.N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature. 383:1996;710-713.
15. Ennaceur A., Meliani K. Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests. Psychopharmacology (Berl). 109:1992;321-330.
16. Hernandez D., Sugaya K., Qu T., McGowan E., Duff K., McKinney M. Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes. Neuroreport. 12:2001;1377-1384.
17. Holcomb L.A., Gordon M.N., Jantzen P., Hsiao K., Duff K., Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations lack of association with amyloid deposits . Behav. Genet. 29:1999;177-185.
18. Iwatsubo T., Mann D.M., Odaka A., Suzuki N., Ihara Y. Amyloid beta protein (A beta) deposition a beta 42(43) precedes A beta 40 in Down syndrome . Ann. Neurol. 37:1995;294-299.
19. Janus C., D'Amelio S., Amitay O., Chishti M.A., Strome R., Fraser P., Carlson G.A., Roder J.C., St George-Hyslop P., Westaway D. Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes. Neurobiol. Aging. 21:2000;541-549.
20. Kelsey J.E., Landry B.A. Medial septal lesions disrupt spatial mapping ability in rats. Behav. Neurosci. 102:1988;289-293.
21. Kelsey J.E., Vargas H. Medial septal lesions disrupt spatial, but not nonspatial, working memory in rats. Behav. Neurosci. 107:1993;565-574.
22. LaFerla F.M., Tinkle B.T., Bieberich C.J., Haudenschild C.C., Jay G. The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9:1995;21-30.
23. Levitan D., Doyle T.G., Brousseau D., Lee M.K., Thinakaran G., Slunt H.H., Sisodia S.S., Greenwald I. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA. 93:1996;14940-14944.
24. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185.
25. Nag S., Yee B.K., Tang F. Reduction in somatostatin and substance P levels and choline acetyltransferase activity in the cortex and hippocampus of the rat after chronic intracerebroventricular infusion of beta-amyloid (1-40). Brain Res. Bull. 50:1999;251-262.
26. Nag S., Tang F., Yee B.K. Chronic intracerebroventricular exposure to beta-amyloid(1-40) impairs object recognition but does not affect spontaneous locomotor activity or sensorimotor gating in the rat. Exp. Brain Res. 136:2001;93-100.
27. Oyama F., Sawamura N., Kobayashi K., Morishima-Kawashima M., Kuramochi T., Ito M., Tomita T., Maruyama K., Saido T.C., Iwatsubo T., Capell A., Walter J., Grunberg J., Ueyama Y., Haass C., Ihara Y. Mutant presenilin 2 transgenic mouse effect on an age-dependent increase of amyloid beta-protein 42 in the brain . J. Neurochem. 71:1998;313-322.
28. Rogaeva E.A., Fafel K.C., Song Y.Q., Medeiros H., Sato C., Liang Y., Richard E., Rogaev E.I., Frommelt P., Sadovnick A.D., Meschino W., Rockwood K., Boss M.A., Mayeux R., St George-Hyslop P. Screening for PS1 mutations in a referral-based series of AD cases 21 novel mutations . Neurology. 57:2001;621-625.
29. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:1996;864-870.
30. Selkoe D.J. Notch and presenilins in vertebrates and invertebrates implications for neuronal development and degeneration . Curr. Opin. Neurobiol. 10:2000;50-57.
31. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., Tonegawa S. Skeletal and CNS defects in presenilin-1-deficient mice. Cell. 89:1997;629-639.
32. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
33. Smythe J.W., Murphy D., Costall B. Benzodiazepine receptor stimulation blocks scopolamine-induced learning impairments in a water maze task. Brain Res. Bull. 41:1996;299-304.
34. Takasugi N., Tomita T., Hayashi I., Tsuruoka M., Niimura M., Takahashi Y., Thinakaran G., Iwatsubo T. The role of presenilin cofactors in the gamma-secretase complex. Nature. 422:2003;438-441.
35. Vaucher E., Fluit P., Chishti M.A., Westaway D., Mount H.T., Kar S. Object recognition memory and cholinergic parameters in mice expressing human presenilin 1 transgenes. Exp. Neurol. 175:2002;398-406.
36. Wong P.C., Zheng H., Chen H., Becher M.W., Sirinathsinghji D.J., Trumbauer M.E., Chen H.Y., Price D.L., Van der Ploeg L.H., Sisodia S.S. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature. 387:1997;288-292.
37. Zhang Z., Hartmann H., Do V.M., Abramowski D., Sturchler-Pierrat C., Staufenbiel M., Sommer B., van de Wetering M., Clevers H., Saftig P., De Strooper B., He X., Yankner B.A. Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature. 395:1998;698-702.